Volume 68, Issue 12 pp. 1598-1604
Original Article

Twenty four-hour helpline access to expert management advice for food-allergy-triggered anaphylaxis in infants, children and young people: a pragmatic, randomized controlled trial

M. M. Kelleher

M. M. Kelleher

Department of Paediatrics & Child Health, University College Cork, Cork, Ireland

Search for more papers by this author
A. DunnGalvin

A. DunnGalvin

Department of Paediatrics & Child Health, University College Cork, Cork, Ireland

Search for more papers by this author
A. Sheikh

A. Sheikh

Allergy & Respiratory Research Group, Centre for Population Health Sciences, The University of Edinburgh, Edinburgh, UK

Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital/Harvard Medical School, USA

Search for more papers by this author
C. Cullinane

C. Cullinane

Department of Paediatrics & Child Health, University College Cork, Cork, Ireland

Search for more papers by this author
J. Fitzsimons

J. Fitzsimons

Department of Paediatrics, Our Lady of Lourdes Hospital, Drogheda, Co Louth, Ireland

Search for more papers by this author
J. O'B. Hourihane

Corresponding Author

J. O'B. Hourihane

Department of Paediatrics & Child Health, University College Cork, Cork, Ireland

Correspondence

Prof. Jonathan O'B. Hourihane, Paediatrics & Child Health, Clinical Investigations Unit, Cork University Hospital, Wilton, Cork, Ireland.

Tel.: +353 21 490 1237

Fax: +353 21 434 5217

E-mail: [email protected]

Search for more papers by this author
First published: 05 December 2013
Citations: 24
Edited by: Bodo Niggemann
Registration: Current Controlled Trials (www.controlled-trials.com) ISRCTN29793562.

Abstract

Background

Anaphylaxis is a life-threatening emergency. If promptly administered, adrenaline is potentially life-saving. Many food-allergic-children/carers are unsure when to use their adrenaline autoinjectors, contributing to a low quality of life and worse outcomes in the setting of an acute allergic reaction.

Objectives

The aim of this study was to assess the effectiveness of 24-hour telephone access to specialist clinical advice on disease-specific quality of life.

Methods

A pragmatic two-arm, parallel-group randomized control trial was conducted. Children/carers (<16 years) with food allergy, trained in adrenaline auto-injector use, were recruited from a hospital-based paediatric allergy clinic. Baseline disease-specific quality of life was ascertained using the validated Food-Allergy-Related Quality-of-Life Questionnaire (FAQLQ), either Parent Form, Child Form or Teenager Form depending on child's age. Participants were then centrally randomized for a 6-month period to 24-hour telephone specialist support line or to usual care. The primary outcome measure was a change in FAQL scores, at one and 6 months postrandomization, compared with baseline. The minimum clinically important difference (MCID) in score is 0.5.

Results

Fifty two children/carers were recruited. FAQL scores remained static in the control group across the three time points. Scores gradually improved in the intervention group, with a significant difference seen at 6 months (T1–T3 Mean difference = −1.5, (CI 0.87–2.25) P < 0.005] Follow-up questionnaires, 6 months after the intervention was removed, T4, showed sustained significant difference between the groups (control M = 3.0; intervention M = 1.1[t = −4.113, P < 0.05]).

Conclusion

The 24-hour helpline improved food-allergy-specific quality of life in children. Six-month intervention support resulted in sustained benefits for at least a further 6 months.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.